321 related articles for article (PubMed ID: 19027622)
1. Social inequality in Pap smear coverage: identifying under-users of cervical cancer screening in Argentina.
Arrossi S; Ramos S; Paolino M; Sankaranarayanan R
Reprod Health Matters; 2008 Nov; 16(32):50-8. PubMed ID: 19027622
[TBL] [Abstract][Full Text] [Related]
2. Use of the Pap test by a population group in Buenos Aires.
Klimovsky E; Matos E
Bull Pan Am Health Organ; 1996 Dec; 30(4):313-21. PubMed ID: 9041742
[TBL] [Abstract][Full Text] [Related]
3. Pap smear screening among urban Southwestern American Indian women.
Risendal B; DeZapien J; Fowler B; Papenfuss M; Giuliano A
Prev Med; 1999 Dec; 29(6 Pt 1):510-8. PubMed ID: 10600432
[TBL] [Abstract][Full Text] [Related]
4. Women's knowledge about cervical cancer, Pap smear and human papillomavirus and its relation to screening in Argentina.
Paolino M; Arrossi S
Women Health; 2011 Jan; 51(1):72-87. PubMed ID: 21391162
[TBL] [Abstract][Full Text] [Related]
5. Social support and cervical and breast cancer screening in Argentinean women from a rural population.
Gamarra CJ; Paz EP; Griep RH
Public Health Nurs; 2009; 26(3):269-76. PubMed ID: 19386062
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
7. [Organized cervical cancer screening for underpriviledged women].
Piana L; Leandri FX; Jacqueme B; Heid P; Corti J; Andrac-Meyer L; Sancho-Garnier H
Bull Cancer; 2007 May; 94(5):461-7. PubMed ID: 17535784
[TBL] [Abstract][Full Text] [Related]
8. Participation in highly subsidized cervical cancer screening by women in Enugu, South-east Nigeria.
Obi SN; Ozumba BC; Nwokocha AR; Waboso PA
J Obstet Gynaecol; 2007 Apr; 27(3):305-7. PubMed ID: 17464818
[TBL] [Abstract][Full Text] [Related]
9. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
Bleggi Torres LF; Werner B; Totsugui J; Collaço LM; Araújo SR; Huçulak M; Boza EJ; Fischer RM; De Laat L; Sobbania LC; Raggio A
Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey.
Hewitt M; Devesa SS; Breen N
Prev Med; 2004 Aug; 39(2):270-8. PubMed ID: 15226035
[TBL] [Abstract][Full Text] [Related]
12. Hispanic acculturation and utilization of cervical cancer screening in the US.
Shah M; Zhu K; Wu H; Potter J
Prev Med; 2006 Feb; 42(2):146-9. PubMed ID: 16297444
[TBL] [Abstract][Full Text] [Related]
13. The need to incorporate routine cervical cancer counselling and screening in the management of women at the outpatient clinics in Nigeria.
Dim CC; Nwagha UI; Ezegwui HU; Dim NR
J Obstet Gynaecol; 2009 Nov; 29(8):754-6. PubMed ID: 19821672
[TBL] [Abstract][Full Text] [Related]
14. Effective cervical cytology screening programmes in middle-income countries: the Chilean experience.
Sepúlveda C; Prado R
Cancer Detect Prev; 2005; 29(5):405-11. PubMed ID: 16188399
[TBL] [Abstract][Full Text] [Related]
15. Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening?
Carlos RC; Fendrick AM; Ellis J; Bernstein SJ
J Am Coll Radiol; 2004 Oct; 1(10):769-76. PubMed ID: 17411698
[TBL] [Abstract][Full Text] [Related]
16. Clinical and cost implications of new technologies for cervical cancer screening: the impact of test sensitivity.
Hutchinson ML; Berger BM; Farber FL
Am J Manag Care; 2000 Jul; 6(7):766-80. PubMed ID: 11067374
[TBL] [Abstract][Full Text] [Related]
17. Use of cancer screening services in Greece and associated social factors: results from the nation-wide Hellas Health I survey.
Dimitrakaki C; Boulamatsis D; Mariolis A; Kontodimopoulos N; Niakas D; Tountas Y
Eur J Cancer Prev; 2009 Jun; 18(3):248-57. PubMed ID: 19491613
[TBL] [Abstract][Full Text] [Related]
18. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing.
Howell LP; Gurusinghe S; Tabnak F; Sciortino S
Cancer Detect Prev; 2009; 32(5-6):372-9. PubMed ID: 19264426
[TBL] [Abstract][Full Text] [Related]
19. Why women still die from cervical cancer.
Masood S
J Fla Med Assoc; 1997; 84(6):379-83. PubMed ID: 9379163
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer screening and demonstration projects to identify barriers to preventing cervical cancer mortality.
Taylor WR; Nadel MR; Smith RA; Hernandez C; Moser M; Friedell GH
Acta Cytol; 1989; 33(4):460-2. PubMed ID: 2546348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
